gms | German Medical Science

G-I-N Conference 2012

Guidelines International Network

22.08 - 25.08.2012, Berlin

SAGE Directory of Cancer Guidelines

Meeting Abstract

  • M. Brouwers - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada
  • E. Rawski - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada
  • L. Bahirathan - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada
  • T. Waldron - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada
  • K. Spithoff - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada
  • C. Zwaal - Department of Oncology, McMaster University, Hamilton, Canada; Capacity Enhancement Program, Canadian Partnership Against Cancer, Hamilton, ON, Canada

Guidelines International Network. G-I-N Conference 2012. Berlin, 22.-25.08.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocP127

DOI: 10.3205/12gin239, URN: urn:nbn:de:0183-12gin2392

Published: July 10, 2012

© 2012 Brouwers et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: The SAGE (Standards and Guidelines Evidence) directory of cancer guidelines is a resource designed to facilitate evidence-based clinical practice, policy formation, and guideline adaptation, and reduce duplication in guideline development.

Context: Developed in 2008, SAGE is a publicly available (http://www.cancerview.ca/sage), searchable database of English language cancer control guidelines and standards released since 2003. Each guideline in SAGE is rated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II). These ratings can be used to measure trends in guideline quality. SAGE also documents guideline development status, including current guidelines, guidelines in progress, those in need of an update and guidelines undergoing updates.

Description: SAGE contains over 1900 indexed records from 271 developer organizations spanning 27 countries and international jurisdictions. There is considerable variability in guideline quality both within and across guideline developers, and AGREE II quality domains of applicability and editorial independence are the poorest performing. SAGE has the ability to provide information on guideline topic gaps and overlap, demonstrating that the majority of guidelines target breast, lung, colorectal and prostate cancers, and focus on the treatment stage of the cancer control continuum. This provides a channel of communication amongst organizational groups and facilitates guideline development partnerships.

Lessons: The value-add of SAGE to mitigate inconsistencies in guideline quality is the appraisal component of its records. It is the ultimate goal that SAGE will continue to assist efforts to leverage positive change in the field of practice guidelines, patient care and system performance in cancer control.